TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania. Show more

1 Great Valley Parkway, Malvern, PA, 19355, United States

Medical Devices
Healthcare

Market Cap

32.94M

52 Wk Range

$0.67 - $2.48

Previous Close

$0.74

Open

$0.78

Volume

71,109

Day Range

$0.71 - $0.80

Enterprise Value

45.76M

Cash

29.71M

Avg Qtr Burn

-5.719M

Insider Ownership

8.45%

Institutional Own.

72.09%

Qtr Updated

09/30/25


Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date